Concepedia

Author

Romano Danesi

University of PisaORCID

Also Known As

Danesi R., FALCONE, ALFREDO, Giuseppe Castaldo, Marcello Tiseo, Marina Elena Cazzaniga, R DANESI, R Danesi, R. DANESI, R. Danesi, RADDINO, Riccardo

663

Publications

18.5K

Citations

70

H-Index

163

Concepts

All Affiliations

University of PisaAzienda Ospedaliera Universitaria PisanaNational Cancer InstituteScuola Superiore Sant'Anna
RD

About

Romano Danesi is an author at University of Pisa specializing in medicine, pharmacology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

40

96

4.2K

2

Natural Sciences

7

7

222

3

Health Sciences

5

5

137

4

Public Health

3

3

75

5

Engineering

1

1

279

Romano Danesi

×

223

Publications

11.2K

Citations

58

H-Index

YearCitations

MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

Elisa Giovannetti, Niccola Funel, Godefridus J. Peters,

Cancer Research

2010

453

Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila,

JAMA Oncology

2018

397

Transcription Analysis of Human Equilibrative Nucleoside Transporter-1 Predicts Survival in Pancreas Cancer Patients Treated with Gemcitabine

Elisa Giovannetti, Mario Del Tacca, Valentina Mey,

Cancer Research

2006

346

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

Marzia Del Re, Elisa Biasco, Stefania Crucitta,

European Urology

2016

279

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

Marzia Del Re, Riccardo Marconcini, G. Pasquini,

British Journal of Cancer

2018

242

Correlation of <i>CDA, ERCC1</i>, and <i>XPD</i> Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile,

Clinical Cancer Research

2008

207

Effect of <i>SLCO1B3</i> Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer

Akinobu Hamada, Tristan M. Sissung, Douglas K. Price,

Clinical Cancer Research

2008

190

Cellular and Pharmacogenetics Foundation of Synergistic Interaction of Pemetrexed and Gemcitabine in Human Non–Small-Cell Lung Cancer Cells

Elisa Giovannetti, Valentina Mey, Sara Nannizzi,

Molecular Pharmacology

2005

177

Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer

Francesco Crea, Elaine M. Hurt, Lesley Mathews,

Molecular Cancer

2011

175

Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells

Elisa Giovannetti, Clara Lemos, Christina Tekle,

Molecular Pharmacology

2008

158

Page 1